Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins - PubMed (original) (raw)
Comparative Study
Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins
E S Krul et al. J Clin Invest. 1985 Feb.
Abstract
Apoproteins B and E both interact with cellular low density lipoprotein (LDL) apolipoprotein B and E (apo B,E)-receptors, and very low density lipoproteins (VLDL) contain both apo B and apo E. Our aim was to study the relative importance of apo B and apo E in the binding of VLDL subfractions to cells. Two monoclonal anti-LDL-apo B antibodies (464B1B3 and 464B1B6, 2a and 2b, respectively) and two anti-apo E antibodies (1506 A1.4 and 1907 F6.4) were used to inhibit lipoprotein-cell interactions. In confirmation of previous findings, the binding and degradation of 125I-LDL by human fibroblasts were inhibited approximately 90% by antibodies 2a or 2b or the antigen-binding fragments of 2a, whereas the cellular processing of 125I-VLDL3 (Sf20-60), 125I-VLDL2 (Sf60-120), and 125I-VLDL1 (Sf greater than 120) were inhibited by only approximately 50%, approximately 25%, and less than 10%, respectively. The VLDL1-3 and LDL-dependent intracellular esterification of cholesterol with [3H]oleate were inhibited to a similar extent. Other monoclonal anti-human apo B antibodies inhibited lipoprotein-cell interactions much less effectively and nonimmune IgG isolated from mouse serum did not inhibit at all. 20-fold excesses of LDL produced about the same patterns of inhibition of degradation of 125I-VLDL1-3 and LDL by cells as did antibodies 2a and 2b, whereas homologous unlabeled VLDL1-3 in like amounts inhibited the matched 125I-VLDL subfraction more effectively. Two anti-apo E monoclonal antibodies and a polyclonal anti-apo E antibody inhibited cell-mediated degradation of and lipoprotein-dependent cholesterol esterification by VLDL1 but not VLDL3 or LDL. The results suggest that receptor recognition sites on apo E in preference to sites on apo B mediate the cellular binding of hypertriglyceridemic VLDL1. However, the proportion of particles bound via apo B seems to increase as VLDL decreases in size toward LDL, and virtually all of LDL binding is mediated by apo B.
Similar articles
- Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor.
Koo C, Wernette-Hammond ME, Innerarity TL. Koo C, et al. J Biol Chem. 1986 Aug 25;261(24):11194-201. J Biol Chem. 1986. PMID: 3733751 - Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
Dashti N, Wolfbauer G. Dashti N, et al. Biochim Biophys Acta. 1986 Feb 28;875(3):473-86. doi: 10.1016/0005-2760(86)90067-6. Biochim Biophys Acta. 1986. PMID: 3004589 - Expression of LDL receptor binding determinants in very low density lipoproteins.
Bradley WA, Gotto AM Jr, Gianturco SH. Bradley WA, et al. Ann N Y Acad Sci. 1985;454:239-47. doi: 10.1111/j.1749-6632.1985.tb11863.x. Ann N Y Acad Sci. 1985. PMID: 3907464 Review. - In vivo studies of VLDL metabolism and LDL heterogeneity.
Demant T, Packard C. Demant T, et al. Eur Heart J. 1998 Jul;19 Suppl H:H7-10. Eur Heart J. 1998. PMID: 9717058 Review.
Cited by
- Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.
Reyes-Soffer G, Pavlyha M, Ngai C, Thomas T, Holleran S, Ramakrishnan R, Karmally W, Nandakumar R, Fontanez N, Obunike J, Marcovina SM, Lichtenstein AH, Matthan NR, Matta J, Maroccia M, Becue F, Poitiers F, Swanson B, Cowan L, Sasiela WJ, Surks HK, Ginsberg HN. Reyes-Soffer G, et al. Circulation. 2017 Jan 24;135(4):352-362. doi: 10.1161/CIRCULATIONAHA.116.025253. Epub 2016 Dec 16. Circulation. 2017. PMID: 27986651 Free PMC article. Clinical Trial. - Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles.
Jiang J, Luo G. Jiang J, et al. J Virol. 2009 Dec;83(24):12680-91. doi: 10.1128/JVI.01476-09. Epub 2009 Sep 30. J Virol. 2009. PMID: 19793818 Free PMC article. - Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.
Chang KS, Jiang J, Cai Z, Luo G. Chang KS, et al. J Virol. 2007 Dec;81(24):13783-93. doi: 10.1128/JVI.01091-07. Epub 2007 Oct 3. J Virol. 2007. PMID: 17913825 Free PMC article. - Identification of a VLDL-induced, FDNPVY-independent internalization mechanism for the LDLR.
Michaely P, Zhao Z, Li WP, Garuti R, Huang LJ, Hobbs HH, Cohen JC. Michaely P, et al. EMBO J. 2007 Jul 25;26(14):3273-82. doi: 10.1038/sj.emboj.7601769. Epub 2007 Jun 21. EMBO J. 2007. PMID: 17581630 Free PMC article. - Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects.
Gianturco SH, Bradley WA. Gianturco SH, et al. Clin Cardiol. 1999 Jun;22(6 Suppl):II7-14. doi: 10.1002/clc.4960221403. Clin Cardiol. 1999. PMID: 10376191 Free PMC article. Review.
References
- Immunochemistry. 1978 Jul;15(7):429-36 - PubMed
- Lipids. 1980 Jun;15(6):456-63 - PubMed
- Biochim Biophys Acta. 1983 May 24;737(2):197-222 - PubMed
- Biochemistry. 1974 Apr 9;13(8):1579-85 - PubMed
- J Cell Biol. 1982 Mar;92(3):833-45 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials